Details:

Alternative Title:
Multistate outbreak of meningitis and stroke associated with potentially contaminated steroid medication
Corporate Authors:
Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration.
Centers for Disease Control and Prevention (U.S.) ; United States. Food and Drug Administration. Less -
Description:
October 8, 2012, 13:10 ET (1:10 PM ET)

CDCHAN-00328-2012-10-08-ADV-N

The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) continue to work closely with state public health departments on a multistate investigation of fungal meningitis among patients who received an epidural steroid injection. Some of these patients also suffered strokes that may have resulted from their infection. These cases are associated with a potentially contaminated steroid medication prepared by New England Compounding Center (NECC), located in Framingham, Mass. This HAN notice provides updated information about the investigation (including a change in the case definition), laboratory findings, an expanded voluntary recall of products, and recommendations for clinicians.


Subject:
[+]
Anti-Inflammatory Agents/adverse Effects
Aspergillus Fumigatus
Disease Outbreaks
Drug Compounding
Drug Contamination
Injections, Epidural
Meningitis, Fungal
Methylprednisolone
Steroids/adverse Effects
Stroke

Series:
HAN ; 328
Document Type:
HAN Health Advisory
Place as Subject:
United States
Collection(s):
Health Alert Network (HAN)
Main Document Checksum:
[+]
urn:sha256:eab4c8e5126212f6860bee0cfd5b162d1b40f284f46a6d796d6b00fe8b16f58b
File Type:

Supporting Files

• No Additional Files

More +